Artilez Injection

Description

Artesunate 60 mg Injection is a fast-acting antimalarial drug used for the treatment of severe and complicated malaria, especially caused by Plasmodium falciparum. It works by rapidly reducing the parasite load in the blood, helping prevent complications and improving patient outcomes.

Manufactured in WHO-GMP certified sterile facilities, this injection ensures high quality, safety, and effectiveness. It is widely used in hospitals, emergency care, and critical care settings, making it a high-demand product for pharma franchise injectable portfolios.

Key Benefits:

✔ Rapid action against malaria parasites
✔ Effective in severe and complicated malaria
✔ Reduces parasite load quickly
✔ Suitable for emergency and hospital use
✔ WHO-GMP certified sterile manufacturing
✔ High demand hospital injectable for pharma franchise

Composition:

Artesunate 60 mg
(Sterile powder with diluent for reconstitution)

Indications / Uses:

Severe malaria
Complicated Plasmodium falciparum malaria
Malaria with organ complications
Emergency antimalarial treatment

Dosage Form:

Injection (IV / IM use)
(To be administered by healthcare professional only)

Packaging:

Vial with sterile diluent
Tamper-proof hospital-grade packaging

Pharma Franchise Opportunity:

We offer Artesunate Injection Pharma Franchise with:

✅ Monopoly franchise rights
✅ WHO-GMP certified sterile injectable manufacturing
✅ High demand hospital and emergency care product
✅ Promotional and marketing support
✅ Competitive pricing with strong profit margins

This product is a valuable addition to anti-infective and critical care pharma franchise portfolios, ensuring strong institutional demand and consistent business growth.